Your Coworker Might Be on BPC-157. He’s Just Not Going to Tell You.

OPINION

Your coworker says his shoulder is finally feeling better.

“Just started stretching,” he says.

Maybe that is the whole story. Maybe it is not.

Peptide culture is increasingly easy to spot. The people participating are harder to count.

A September 2026 preprint, not yet peer reviewed, identified 1,039 patients whose clinical notes appeared to confirm BPC-157 administration. Reuters reported that the researchers reviewed more than 15 million medical records. That is not a national prevalence estimate. It is a glimpse of what becomes visible when use reaches a searchable clinical note.

What the records show—and what they cannot count

Visible in the study	Still unknown
1,039 patients with notes appearing to confirm BPC-157 administration.	How many people used it without disclosure, documentation, or inclusion in the records searched.
Quarterly newly confirmed users rose about 33-fold from 2020 to 2026.	National prevalence. Growth in documented cases is not a measurement of growth across the whole population.

The culture is visible. The denominator is not.

BPC-157 does not leave the tidy prescription trail of a pharmacy claim and an insurance code. Much of the conversation lives in private clinics, group chats, gyms and the part of the internet where the product page says “for research use only” while the mouse placing the order owns a credit card.

How many people used it and never mentioned it?

Nobody knows.

How many ordered something labeled BPC-157 without ever entering a medical record?

Nobody knows.

The peptide underground is no longer very underground.

It is just socially discreet.

Peptides have become the wellness version of an open secret

The weirdness became almost perfect this week.

The Verge reported on October 20 that TikTok had begun restricting searches for several popular peptide terms, including BPC-157 and retatrutide. Searching some of the names can return no results even while peptide videos, alternate spellings and adjacent content remain available.

That same day, Reuters reported that U.S. Health Secretary Robert F. Kennedy Jr. said the administration wanted a regulated marketplace for peptides, arguing that Americans were going to buy them anyway.

Pause there.

One of the world’s largest social platforms is making some peptide terms harder to search at roughly the same cultural moment that the federal government is publicly discussing what to do about the fact that people are already buying them.

That is not fringe-subculture behavior anymore.

That is what happens when a subculture begins colliding with institutions built for the mainstream.

Harvard’s T.H. Chan School of Public Health published an explainer this month because peptides are now “all over social media and the news.”

At some point the phrase “niche biohacking” stops explaining what is happening.

The better description may be quiet mass curiosity.

BPC-157 is only the most obvious member of the secret club

BPC-157 owns the recovery lane.

The mythology is almost perfectly designed for people who train: tendon problems, joint pain, old injuries, muscle recovery, the nagging thing that is not bad enough for surgery but refuses to leave.

Then there is TB-500, commonly paired with BPC-157 in what internet culture calls the “Wolverine stack.”

Nobody named it the “carefully controlled longitudinal musculoskeletal evidence stack.”

It is Wolverine.

Then the peptide conversation moves into an entirely different demographic with GHK-Cu, the copper peptide associated online with skin, hair and cosmetic aging.

Creator-marketing firm Upfluence tracked 20 peptide terms across Instagram, TikTok and YouTube and reported that GHK-Cu mentions grew almost tenfold between mid-2025 and the second quarter of 2026. Its data showed a predominance of women among creators posting about GHK-Cu, while BPC-157 remained prominent in longer-form YouTube recovery content.

Those are social-media mentions, not proof of product use.

But culturally they matter because they show peptides escaping the old stereotype.

The peptide user is no longer necessarily the shirtless biohacker with a freezer full of vials.

She may be a skincare obsessive who started with a copper serum.

He may be a recreational runner who discovered BPC-157 while searching for an answer to Achilles pain.

Someone else may be talking about MOTS-c and mitochondrial signaling.

Another person may have arrived through Semax or Selank because the conversation shifted from recovery to cognition.

The communities overlap, but they do not look identical.

That is how a category becomes a culture.

Nobody wants to call what they are doing “taking experimental drugs”

Language is doing a lot of work here.

People rarely say:

“I have begun self-experimenting with an investigational biologically active compound that lacks conventional approval for this purpose.”

They say:

“I’m running a peptide.”

Or:

“I’m trying a recovery protocol.”

Or:

“I’m doing a little BPC.”

The vocabulary changes the identity of the act.

“Drug” sounds pharmaceutical.

“Steroid” sounds like a social category.

“Medication” sounds like an illness.

“Peptide” sounds like biology.

And protocol sounds like you have a clipboard.

This may be one reason the culture can grow while remaining oddly private. Many users do not appear to think of themselves as belonging to a drug subculture at all.

They think they are optimizing.

They are recovering.

They are experimenting.

The secrecy is not always shame.

Sometimes it is identity management.

The taboo is doing something strange to word-of-mouth

Traditional health products want public testimonials.

Peptides thrive on semi-private testimonials.

The most persuasive conversation may not be an influencer shouting into a camera. It may be the friend who leans over at dinner and says:

“I probably shouldn’t tell you this, but…”

That sentence is marketing gold.

The secrecy makes the information feel scarce.

The uncertainty makes personal experience feel more valuable.

The lack of standardized access means the person who “knows a guy” suddenly has social capital.

Someone’s shoulder feels better.

Someone’s skin looks better.

Maybe the compound did it.

Maybe rehabilitation did it.

Maybe time did it.

Maybe the vial contained exactly what the label said.

Maybe it did not.

But culture does not wait for those questions to be resolved before it spreads.

Culture moves on stories.

Your coworker is a joke. The hidden-use problem is not.

I do not have data showing that the person in the next cubicle is using BPC-157, or that one in ten people at your gym is on peptides. No credible national prevalence estimate supports that claim.

What we have is growing documented use, expanding public attention and a measurement problem. That is enough to support an opinion:

peptide use is probably culturally larger than its visible public identity suggests.

Not because everybody is secretly pinning something. Because the systems we use to count the behavior are poorly aligned with how it happens.

The communities do not even agree with one another. The skincare obsessive may have no interest in BPC-157. The runner may think MOTS-c sounds absurd. Yet the same idea keeps circulating: small biological molecules can be tools.

The first peptide is weird.

The second peptide is research.

The third peptide is a spreadsheet.

Looking at the laboratory side of peptides? Explore Olympus Peptide Labs, a commercial catalog for in vitro research—not human treatment.

Mainstream culture is arriving before mainstream etiquette

We have rules for talking about alcohol, testosterone, antidepressants, Ozempic, Botox and creatine.

Peptides do not yet have stable social etiquette.

Do you tell your doctor?

Your trainer?

Your partner?

Do you say you are “on” BPC-157?

Do you say you “tried” it?

Do you count topical GHK-Cu in the same conversation as an injectable recovery compound?

Nobody has agreed on the language because the culture arrived faster than the vocabulary.

People are talking about peptides everywhere.

They are just not necessarily talking about their peptides.

The next phase will be disclosure

Your coworker may really have started stretching. We cannot infer his treatment from his shoulder.

But the private conversation may not stay private forever.

The coworker with the shoulder.

The woman with the copper-peptide skincare routine.

The runner with the suspiciously detailed opinion about BPC-157.

The friend who knows what bacteriostatic water is but would like you to believe this knowledge arrived accidentally.

Maybe none of them are taking anything.

Maybe one is.

Maybe all four are.

We do not have the denominator.

That uncertainty is not a reason to invent one.

It is the story.

The peptide craze may already be much less underground than the people participating in it still behave.

And once a culture reaches the point where TikTok is hiding the search term while Washington debates how to regulate the market, “secret” starts to become a very temporary description.

Curious about the science behind the culture?

Our BPC-157 evidence guide separates what has been studied in people from what remains unproven. You can be curious without pretending the science is finished.

For laboratory research, visit Olympus Peptide Labs. The site states that its products are for adults 21 and older, strictly for in vitro research—not personal use.

The culture got here first. The evidence still has work to do.

---

Opinion note: This article intentionally uses rhetorical and hypothetical examples (“your coworker,” “your neighbor,” “the guy at your gym”) to describe a cultural trend. They are not prevalence estimates or claims about identifiable people. Social-media mention data are not evidence of use. BPC-157, TB-500 and several other compounds discussed in contemporary peptide culture are not FDA-approved for the popular wellness uses described here.

Editorial disclosure: Prepared with AI assistance; not yet reviewed by a qualified medical or scientific professional. This cultural opinion piece is not medical advice or a recommendation to use unapproved peptides.

Sources: Clinical-notes preprint · TikTok reporting · Reuters policy report · Creator-data study.

Commercial-link note: The Olympus links lead to a business selling research-use products. They are not evidence that these compounds are safe or effective for personal use.